Nulligravid | Gravid | ||
---|---|---|---|
(n=33) | (n=78) | p Value | |
ANA, antinuclear antibodies; Scl-70, antitopoisomerase I antibodies; ACA, anticentromere antibodies. | |||
Gastrointestinal involvement | 25/33 (76) | 55/78 (71) | 0.64 |
Pulmonary symptoms | 20/33 (61) | 31/78 (40) | 0.06 |
Cardiac symptoms | 9/33 (27) | 27/78 (35) | 0.51 |
Renal crisis | 4/33 (12) | 8/78 (10) | 0.73 |
Mean Tlco | 64.6 | 73.7 | 0.10 |
Tlco<60/>10 years' duration | 10/13 (77) | 10/23 (43) | 0.05 OR=4.7 |
Tlco<50/>10 years' duration | 7/13 (54) | 6/23 (26) | 0.09 OR=3.2 |
Mortality | 7/30 (23) | 3/78 (4) | 0.0058 OR=7.6 |
ANA+ | 29/30 (97) | 67/73 (92) | 0.67 |
Scl-70+ | 7/30 (23) | 14/75 (19) | 0.78 |
ACA+ | 9/30 (30) | 19/75 (25) | 0.81 |
ANA+, Scl-70− ACA− | 12/30 (40) | 42/75 (56) | 0.13 |